🇺🇸 FDA
Pipeline program

Placebo for ACP-204 capsules

ACP-204

Phase 2 small_molecule active

Quick answer

Placebo for ACP-204 capsules for Lewy Body Dementia Psychosis (LBDP) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Lewy Body Dementia Psychosis (LBDP)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials